InvestmentApr 16, 2026, 07:01 AM
Adlai Nortye Secures $150M in Oversubscribed PIPE Financing
AI Summary
Adlai Nortye Ltd. announced an oversubscribed private investment in public equity (PIPE) financing, expected to generate approximately $150.0 million in gross proceeds. The company is selling 11,320,755 ADSs at a price of $13.25 per ADS to a mix of new and existing institutional investors. This capital infusion will support the development of its innovative RAS-targeting therapies and next-generation ADC payload platform, RASiCA", as the company aims to transform cancer treatment.
Key Highlights
- Secured approximately $150.0 million in gross proceeds.
- Sold 11,320,755 ADSs at $13.25 per ADS.
- Oversubscribed with participation from new and existing institutional investors.
- Expected to close on April 17, 2026.